Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-010332
Filing Date
2025-03-31
Accepted
2025-03-31 20:05:01
Documents
1
Period of Report
2025-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2787
  Complete submission text file 0001437749-25-010332.txt   4380
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 22045 KAREN STREET ELKHORN NE 68022
Business Address
Watton Corey Michael (Reporting) CIK: 0001975404 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 25796000